Journal of Cell Science & Therapy
Open Access

The Potential Mechanism of Neural Stem Cell Therapy for Repairing Central Nervous System

Narihito Nagoshi^{* *}Correspondence: Narihito Nagoshi, Department of Infectious Diseases, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan, Email:

Author info »

Description

Neural stem cell therapy has emerged as a promising frontier in the field of regenerative medicine, offering a novel approach to treat neurological disorders and injuries. The potential of Neural Stem Cells (NSCs) to differentiate into various neural cell types, repair damaged tissue, and promote functional recovery has spurred a wave of research and clinical trials. However, alongside the tremendous therapeutic promise, it is crucial to explore preventive measures to ensure the safety and efficacy of neural stem cell therapy.

The promise of neural stem cell therapy

Neural stem cells possess the remarkable ability to self-renew and differentiate into different cell types within the nervous system, including neurons, astrocytes, and oligodendrocytes. This inherent versatility makes them a potent tool for addressing a wide range of neurological disorders such as Parkinson's disease, Alzheimer's disease, spinal cord injuries, and stroke. In neurodegenerative conditions, where the loss of specific cell types is a sign, NSC therapy offers a unique solution by replacing damaged or degenerated cells. This regeneration can potentially restore lost function and ameliorate symptoms, marking a departure from traditional symptom management approaches [1,2].

Preventive measures in neural stem cell therapy

As the field of neural stem cell therapy advances, ensuring its safety and efficacy becomes paramount. Several preventive measures must be considered to address potential challenges and maximize the therapeutic benefits:

Ethical considerations and regulation: Ethical guidelines and regulatory frameworks should be established to govern the ethical sourcing, handling, and application of neural stem cells. Stringent oversight ensures that research and clinical applications adhere to ethical standards, preventing misuse and promoting responsible advancements [3,4].

Patient selection and individualized treatment plans: Careful patient selection based on the specific characteristics of the neurological disorder is essential. Tailoring treatment plans to individual patients can enhance the efficacy of neural stem cell therapy, taking into account factors such as age, disease stage, and overall health [5].

Optimizing cell sources: The source of neural stem cells is a critical consideration. Whether derived from embryonic, fetal, or adult tissues, each source has its advantages and challenges. Rigorous studies are needed to determine the most suitable cell source for different applications, ensuring optimal safety and efficacy [6,7].

Immunosuppression strategies: Transplanted cells may trigger immune responses, potentially limiting their survival and efficacy. Developing effective immunosuppression strategies is crucial to enhance the integration of neural stem cells into the host tissue, preventing rejection and promoting long-term therapeutic effects [8].

Monitoring and imaging techniques: Continuous monitoring of transplanted cells is necessary to track their migration, differentiation, and integration into the host tissue. Advanced imaging techniques, such as MRI and PET scans, play a vital role in assessing the success of neural stem cell therapy and identifying potential complications.

Long-term safety studies: Comprehensive long-term safety studies are imperative to evaluate the durability of therapeutic effects and identify any potential adverse events. Understanding the long-term impact of neural stem cell therapy is essential for establishing its viability as a sustainable treatment option [9].

Combination therapies: Exploring synergies with other therapeutic approaches, such as pharmacological interventions or rehabilitation strategies, can enhance the overall outcomes of neural stem cell therapy. Combining treatments may address multiple aspects of neurological disorders, providing a more comprehensive and effective solution [10].

Conclusion

Neural stem cell therapy holds immense promise in revolutionizing the treatment of neurological disorders, offering a unique approach to repair and regeneration. However, the realization of this potential hinges on the implementation of robust preventive measures to address ethical, safety, and efficacy concerns. As research progresses, the collaboration between scientists, clinicians, ethicists, and regulatory bodies becomes crucial to navigating the complex landscape of neural stem cell therapy. By embracing a multidisciplinary approach and prioritizing safety considerations, the field can unlock the full therapeutic potential of neural stem cells, paving the way for transformative advancements in neurological medicine.

References

1. Shultz RB, Zhong Y. Hydrogel-based local drug delivery strategies for spinal cord repair. Neural Regen Res. 2021;16(2):247. 

   [CrossRef] [Google Scholar] [PubMed]

2. Alizadeh A, Dyck SM, Karimi-Abdolrezaee S. Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms. Front Neurol. 2019;10:282.

   [CrossRef] [Google Scholar] [PubMed]

3. Brockie S, Hong J, Fehlings MG. The role of microglia in modulating neuroinflammation after spinal cord injury. Int J Mol Sci. 2021;22(18):9706. 

   [CrossRef] [Google Scholar] [PubMed]

4. Pan W, Kastin AJ. Cytokine transport across the injured blood-spinal cord barrier. Curr Pharm Des. 2008;14(16):1620-1624. 

   [CrossRef] [Google Scholar] [PubMed]

5. Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol. 2008;209(2):378-388.

   [CrossRef] [Google Scholar] [PubMed]

6. Pukos N, Goodus MT, Sahinkaya FR, McTigue DM. Myelin status and oligodendrocyte lineage cells over time after spinal cord injury: What do we know and what still needs to be unwrapped?. Glia. 2019;67(11):2178-202. 

   [CrossRef] [Google Scholar] [PubMed]

7. Lytle JM, Chittajallu R, Wrathall JR, Gallo V. NG2 cell response in the CNP‐EGFP mouse after contusive spinal cord injury. Glia. 2009;57(3):270-85. 

   [CrossRef] [Google Scholar] [PubMed]

8. Hackett AR, Lee JK. Understanding the NG2 glial scar after spinal cord injury. Front Neurol. 2016;7:199.

   [CrossRef] [Google Scholar] [PubMed]

9. Sofroniew MV. Astrocyte reactivity: subtypes, states, and functions in CNS innate immunity. Trends Immunol. 2020;41(9):758-70.

   [CrossRef] [Google Scholar] [PubMed]

10. Anderson MA, Burda JE, Ren Y, Ao Y, O’Shea TM, Kawaguchi R, et al. Astrocyte scar formation aids central nervous system axon regeneration. Nature. 2016;532(7598):195-200.

    [CrossRef] [Google Scholar] [PubMed]